See also this year's filing and all EDGAR filings for this company.
PDF Report 0001821323_2022_Sigilon_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001821323, Sigilon Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 126,394,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,994,000 |
| 3 | remainder_Assets | 13,981,000 |
| 4 | LiabilitiesCurrent | 34,888,000 |
| 5 | LiabilitiesNoncurrent | 26,988,000 |
| 6 | remainder_Liabilities | 5,333,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,166,000 |
| 9 | ResearchAndDevelopmentExpense | 65,069,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 9,599,000 |
| 12 | remainder_NetIncome | -1,675,000 |
| 13 | remainder_ComprehensiveNetIncome | -10,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 144,369,000 |
| 1 | Liabilities | 67,209,000 |
| 2 | Expenses | 85,235,000 |
| 3 | Revenues | 9,599,000 |
| 4 | StockholdersEquity | 77,160,000 |
| 5 | NetIncome | -77,311,000 |
| 6 | ComprehensiveNetIncome | -77,316,000 |
| 7 | BaseVar | 154,048,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.859 |
| 9 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
